vs
美国鹰(AEO)与Astrana Health, Inc.(ASTH)财务数据对比。点击上方公司名可切换其他公司
美国鹰的季度营收约是Astrana Health, Inc.的1.4倍($1.4B vs $950.5M),美国鹰净利率更高(6.7% vs 0.7%,领先6.0%),Astrana Health, Inc.同比增速更快(42.9% vs 5.7%),美国鹰自由现金流更多($-2.5M vs $-6.0M),过去两年Astrana Health, Inc.的营收复合增速更高(53.3% vs 2.3%)
American Eagle Outfitters是美国知名服饰及配饰零售商,总部位于宾夕法尼亚州匹兹堡市南区工业园。品牌1977年由杰里·西尔弗曼与马克·西尔弗曼兄弟创立,最初为零售风险投资公司的子公司,旗下还运营西尔弗曼男装。1980年创始人向肖滕斯坦家族出售一半股权,1991年售罄剩余股份,目前旗下拥有Aerie、Unsubscribed等多个品牌。
Astrana Health是一家总部位于美国的价值导向型医疗服务提供商,主要服务全美符合联邦医保资格的老年群体,提供上门初级护理、慢性病管理及护理协调服务,致力于提升患者健康水平、降低不必要的医疗支出。
AEO vs ASTH — 直观对比
营收规模更大
AEO
是对方的1.4倍
$950.5M
营收增速更快
ASTH
高出37.2%
5.7%
净利率更高
AEO
高出6.0%
0.7%
自由现金流更多
AEO
多$3.4M
$-6.0M
两年增速更快
ASTH
近两年复合增速
2.3%
损益表 — Q3 FY2026 vs Q4 FY2025
| 指标 | ||
|---|---|---|
| 营收 | $1.4B | $950.5M |
| 净利润 | $91.3M | $6.6M |
| 毛利率 | 40.5% | — |
| 营业利润率 | 8.3% | 1.9% |
| 净利率 | 6.7% | 0.7% |
| 营收同比 | 5.7% | 42.9% |
| 净利润同比 | 14.2% | 184.4% |
| 每股收益(稀释后) | $0.53 | $0.12 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
AEO
ASTH
| Q4 25 | $1.4B | $950.5M | ||
| Q3 25 | $1.3B | $956.0M | ||
| Q2 25 | $1.1B | $654.8M | ||
| Q1 25 | — | $620.4M | ||
| Q4 24 | $1.3B | $665.2M | ||
| Q3 24 | $1.3B | $478.7M | ||
| Q2 24 | $1.1B | $486.3M | ||
| Q1 24 | $1.7B | $404.4M |
净利润
AEO
ASTH
| Q4 25 | $91.3M | $6.6M | ||
| Q3 25 | $77.6M | $373.0K | ||
| Q2 25 | $-64.9M | $9.4M | ||
| Q1 25 | — | $6.7M | ||
| Q4 24 | $80.0M | $-7.8M | ||
| Q3 24 | $77.3M | $16.1M | ||
| Q2 24 | $67.8M | $19.2M | ||
| Q1 24 | $6.3M | $14.8M |
毛利率
AEO
ASTH
| Q4 25 | 40.5% | — | ||
| Q3 25 | 38.9% | — | ||
| Q2 25 | 29.6% | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 40.9% | — | ||
| Q3 24 | 38.6% | — | ||
| Q2 24 | 40.6% | — | ||
| Q1 24 | 36.6% | — |
营业利润率
AEO
ASTH
| Q4 25 | 8.3% | 1.9% | ||
| Q3 25 | 8.0% | 2.0% | ||
| Q2 25 | -7.8% | 3.1% | ||
| Q1 25 | — | 3.3% | ||
| Q4 24 | 8.2% | 0.1% | ||
| Q3 24 | 7.8% | 5.9% | ||
| Q2 24 | 6.8% | 6.2% | ||
| Q1 24 | 0.6% | 7.5% |
净利率
AEO
ASTH
| Q4 25 | 6.7% | 0.7% | ||
| Q3 25 | 6.0% | 0.0% | ||
| Q2 25 | -6.0% | 1.4% | ||
| Q1 25 | — | 1.1% | ||
| Q4 24 | 6.2% | -1.2% | ||
| Q3 24 | 6.0% | 3.4% | ||
| Q2 24 | 5.9% | 3.9% | ||
| Q1 24 | 0.4% | 3.7% |
每股收益(稀释后)
AEO
ASTH
| Q4 25 | $0.53 | $0.12 | ||
| Q3 25 | $0.45 | $0.01 | ||
| Q2 25 | $-0.36 | $0.19 | ||
| Q1 25 | — | $0.14 | ||
| Q4 24 | $0.41 | $-0.14 | ||
| Q3 24 | $0.39 | $0.33 | ||
| Q2 24 | $0.34 | $0.40 | ||
| Q1 24 | $0.03 | $0.31 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $112.8M | $429.5M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $1.6B | $779.3M |
| 总资产 | $4.2B | $2.2B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势,按日历期对齐
现金及短期投资
AEO
ASTH
| Q4 25 | $112.8M | $429.5M | ||
| Q3 25 | $126.8M | $463.4M | ||
| Q2 25 | $87.9M | $342.1M | ||
| Q1 25 | — | $260.9M | ||
| Q4 24 | $160.2M | $290.8M | ||
| Q3 24 | $191.8M | $350.3M | ||
| Q2 24 | $300.5M | $327.7M | ||
| Q1 24 | $454.1M | $337.3M |
总债务
AEO
ASTH
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $0 | — | ||
| Q3 24 | $0 | — | ||
| Q2 24 | $0 | — | ||
| Q1 24 | $0 | — |
股东权益
AEO
ASTH
| Q4 25 | $1.6B | $779.3M | ||
| Q3 25 | $1.5B | $775.5M | ||
| Q2 25 | $1.5B | $765.5M | ||
| Q1 25 | — | $745.4M | ||
| Q4 24 | $1.7B | $712.7M | ||
| Q3 24 | $1.7B | $704.6M | ||
| Q2 24 | $1.8B | $678.9M | ||
| Q1 24 | $1.7B | $653.5M |
总资产
AEO
ASTH
| Q4 25 | $4.2B | $2.2B | ||
| Q3 25 | $4.1B | $2.2B | ||
| Q2 25 | $3.8B | $1.4B | ||
| Q1 25 | — | $1.3B | ||
| Q4 24 | $3.7B | $1.4B | ||
| Q3 24 | $3.5B | $1.3B | ||
| Q2 24 | $3.6B | $1.3B | ||
| Q1 24 | $3.6B | $1.2B |
负债/权益比
AEO
ASTH
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 0.00× | — | ||
| Q3 24 | 0.00× | — | ||
| Q2 24 | 0.00× | — | ||
| Q1 24 | 0.00× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $67.1M | $-2.9M |
| 自由现金流经营现金流 - 资本支出 | $-2.5M | $-6.0M |
| 自由现金流率自由现金流/营收 | -0.2% | -0.6% |
| 资本支出强度资本支出/营收 | 5.1% | 0.3% |
| 现金转化率经营现金流/净利润 | 0.74× | -0.44× |
| 过去12个月自由现金流最近4个季度 | $-169.8M | $104.5M |
8季度趋势,按日历期对齐
经营现金流
AEO
ASTH
| Q4 25 | $67.1M | $-2.9M | ||
| Q3 25 | $27.8M | $10.0M | ||
| Q2 25 | $-54.7M | $90.9M | ||
| Q1 25 | — | $16.6M | ||
| Q4 24 | $52.9M | $-10.9M | ||
| Q3 24 | $78.3M | $34.0M | ||
| Q2 24 | $-38.1M | $23.2M | ||
| Q1 24 | $296.4M | $6.0M |
自由现金流
AEO
ASTH
| Q4 25 | $-2.5M | $-6.0M | ||
| Q3 25 | $-43.1M | $7.4M | ||
| Q2 25 | $-116.3M | $89.5M | ||
| Q1 25 | — | $13.6M | ||
| Q4 24 | $-7.8M | $-13.5M | ||
| Q3 24 | $17.5M | $31.7M | ||
| Q2 24 | $-74.3M | $20.4M | ||
| Q1 24 | $256.8M | $5.6M |
自由现金流率
AEO
ASTH
| Q4 25 | -0.2% | -0.6% | ||
| Q3 25 | -3.4% | 0.8% | ||
| Q2 25 | -10.7% | 13.7% | ||
| Q1 25 | — | 2.2% | ||
| Q4 24 | -0.6% | -2.0% | ||
| Q3 24 | 1.4% | 6.6% | ||
| Q2 24 | -6.5% | 4.2% | ||
| Q1 24 | 15.3% | 1.4% |
资本支出强度
AEO
ASTH
| Q4 25 | 5.1% | 0.3% | ||
| Q3 25 | 5.5% | 0.3% | ||
| Q2 25 | 5.7% | 0.2% | ||
| Q1 25 | — | 0.5% | ||
| Q4 24 | 4.7% | 0.4% | ||
| Q3 24 | 4.7% | 0.5% | ||
| Q2 24 | 3.2% | 0.6% | ||
| Q1 24 | 2.4% | 0.1% |
现金转化率
AEO
ASTH
| Q4 25 | 0.74× | -0.44× | ||
| Q3 25 | 0.36× | 26.69× | ||
| Q2 25 | — | 9.65× | ||
| Q1 25 | — | 2.48× | ||
| Q4 24 | 0.66× | — | ||
| Q3 24 | 1.01× | 2.11× | ||
| Q2 24 | -0.56× | 1.21× | ||
| Q1 24 | 46.93× | 0.40× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
AEO
| American Eagle Brand | $800.4M | 59% |
| Aerie Brand | $429.1M | 31% |
| Other | $133.2M | 10% |
ASTH
| Medicare | $542.4M | 57% |
| Commercial | $99.1M | 10% |
| Care Delivery | $92.1M | 10% |
| Care Enablement | $78.9M | 8% |
| Other Third Parties | $58.0M | 6% |
| Health Care Patient Service | $39.8M | 4% |
| Health Care Other | $25.5M | 3% |
| Other | $12.1M | 1% |
| Management Service | $10.3M | 1% |